Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018Research in context

Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018Research in context

Summary: Background: Historically, survivors of common lymphoid neoplasms (LNs) had increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML). Despite major treatment advances in the treatment of LNs over the last two decades, a comprehensive evaluation of tMDS/...

Full description

Bibliographic Details
Main Authors: Lindsay M. Morton, Rochelle E. Curtis, Martha S. Linet, Sara J. Schonfeld, Pragati G. Advani, Nicole H. Dalal, Elizabeth C. Sasse, Graça M. Dores
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:EClinicalMedicine
Subjects:
Treatment-related leukemia
Lymphoma
Lymphoid neoplasm
Survivorship
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023002377

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023002377

Similar Items